Post-partum dilated cardiomyopathy in anti-phospholipid positive woman

M. L. Airoldi, O. Eid, C. Tosetto, P. L. Meroni

Research output: Contribution to journalArticlepeer-review


Recurrent fetal loss and pregnancy complications, especially severe early-onset preeclampsia, are frequently associated with anti-phospholipid antibodies. We report a case of postpartum cardiac involvement leading to dilated cardiomyopathy in a woman with a persistent positivity for anti-cardiolipin and anti-nuclear antibodies. Her clinical and obstetric record reported two previous fetal losses but no other signs characteristic of the anti-phospholipid syndrome or diagnostic for a systemic lupus erythematosus. Post-partum cardiomyopathy might be another cardiac presentation of the anti-phospholipid syndrome, in addition to the well known valvular involvement. In patients with persistent positivities for anti-phospholipid antibodies, a prompt identification of such a complication in the postpartum period should be taken into account by physicians. Adequate cardiologic treatment associated with antiaggregant and steroid therapy might be useful to prevent further complications in these patients.

Original languageEnglish
Pages (from-to)247-250
Number of pages4
Issue number3
Publication statusPublished - 1996


  • Anti-cardiolipin antibodies
  • Anti-phospholipid syndrome
  • Post-partum cardiomyopathy

ASJC Scopus subject areas

  • Rheumatology
  • Immunology


Dive into the research topics of 'Post-partum dilated cardiomyopathy in anti-phospholipid positive woman'. Together they form a unique fingerprint.

Cite this